News & Press Releases

UNEEG Medical boosts European commercialization and is on track for launch in the U.S.

3/9/2026

COPENHAGEN, MARCH 9, 2026 – In the 2024/25 financial year, UNEEG Medical sharpened the company's focus on ensuring sustainable, early commercialization in Europe and preparing for launch on the US market, building on previous years' significant technological developments and successful clinical trials.

UNEEG Medical marks first pediatric implantation in Europe-led study

1/8/2026

COPENHAGEN, January 8, 2026 – UNEEG Medical is proud to announce a groundbreaking milestone: for the first time, a child has been included in a clinical study using UNEEG’s ultra long-term brain monitoring solution.

UNEEG medical Achieves EU Approval for 3-Year Continuous Use of UNEEG SubQ Implant – Further Strengthening its EpiSight Solution for Epilepsy Monitoring

6/11/2025

COPENHAGEN, June 11, 2025 – UNEEG medical, a Danish company at the forefront of neuro- and epilepsy science, proudly announces the EU approval for 3-year continuous use of its subcutaneous implant, which is a significant milestone for the UNEEG EpiSight solution.

New CEO at UNEEG medical

3/7/2025

Martin Stenfeldt has taken over as new CEO of UNEEG medical. He succeeds Torben Sandgren, who has chosen to resign from his position after 7 years of dedicated service.

UNEEG receives FDA Breakthrough Device Designation

11/22/2024

The designation is a result of UNEEG’s strong focus on developing novel disease management support tools with transformational and first-to-market potential.

Red Dot Award to UNEEG medical

10/10/2024

UNEEG medical won the Red Dot Award for the design of UNEEG EpiSight.

UNEEG EpiSight launch

9/7/2024

UNEEG medical announces world's first wireless, ultra long-term EEG recording of people with severe epilepsy – breakthrough features AI-supported analytics software for seizure and sleep correlation.

REAL-ASE Study

12/8/2023

We have reached an exciting milestone in the UK: Yesterday, the first patient in the REAL-ASE study had the 24/7 EEG™ SubQ implanted.

Policy Lab workshop

11/17/2023

Our colleagues were in London yesterday to participate at a Policy Lab workshop held at The Policy Institute at King’s College London.

Green Smiley to UNEEG medical

9/19/2023

UNEEG medical has received a Green Smiley from the Work Environment in Denmark.

New award for SubQ project in epilepsy

11/24/2022

UNEEG medical UK has received a £98,405 award for a SubQ EEG project in epilepsy aimed at people with intellectual disabilities or autism.

£1.8 million for real-world testing of 24/7 EEG SubQ

10/4/2022

UNEEG medical and King’s College London have been rewarded £1.8 million for real-world testing of our subcutaneous EEG solution.